Ridenour, Ty A. http://orcid.org/0000-0002-9709-6808
Cruden, Gracelyn
Yang, Yang
Bonar, Erin E.
Rodriguez, Anthony
Saavedra, Lissette M.
Hussong, Andrea M.
Walton, Maureen A.
Deeds, Bethany
Ford, Jodi L.
Knight, Danica K.
Haggerty, Kevin P.
Stormshak, Elizabeth
Kominsky, Terrence K.
Ahrens, Kym R.
Woodward, Diana
Feng, Xin
Fiellin, Lynn E.
Wilens, Timothy E.
Klein, David J.
Fernandes, Claudia-Santi
Funding for this research was provided by:
National Institute on Drug Abuse (UH3DA050234, UH3DA050252, UH3DA050193, UH3DA050235, U24DA050182, UG3DA050189, UH3DA050174, UH3DA050250, UH3DA050173, P50DA048756, UG3DA050251)
Article History
Accepted: 18 July 2022
First Online: 17 August 2022
Declarations
:
: All studies that are described or referenced herein have been reviewed and approved by the Investigators’ respective Institutional Review Boards. All procedures with human subjects were performed in accordance with the ethical standards of the institute and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: N/A.
: The authors declare that they have no conflict of interest.